Uquifa is a European leader in contract development and manufacturing for small molecules with a sharp focus on delivering high quality products with speed. With locations in North America and Europe, Uquifa is perfectly positioned to support customers with their New Chemical Entity programs, every step of the way, on their journey from pre-clinical to commercial. Uquifa’ sites have been successfully inspected and approved by major regulatory bodies, including US FDA, HEALTH CANADA, EMA, PMDA, KOREAN FDA, ANVISA and COFEPRIS. At Uquifa, our customers and partners are at the core of everything we do and our identity, ‘Uquifa, Chemistry for a better life’ sprouts not only from over 80 years of experience developing and manufacturing small molecules, but also from our strength in science brought to us by collaborations with thought leaders in the field of Chemistry. Uquifa also has a portfolio of Active Pharmaceutical Ingredients (APIs) available to our customers with over 150 active DMF´s filed and 26 COS approved.
